Daily Management Review

Pfizer & Merck’s Joint Venture In Diabetes Drug Gets EMA Committee’s Recommendation


01/27/2018


Steglatro will be treating type II diabetes orally.



One panel of European Medicines Agency, shortly called EMA, has come up with a recommendation of “granting marketing approval” towards a drug for diabetes that has been jointly developed by Merck & Co and Pfizer Inc.
 
The said recommendation of the EMA panel for “Medicinal Products for Human Use” can be a booster to the European Commission bound companies. The drug, an oral treatment used for treating “Type II diabetes”, will be coming to the market under the name of Steglatro.
 
Steglatro is a “SGLT2 inhibitors” which will help the patients’ “excess glucose” to be expelled “through urine”. While Reuters added:
“In December, Merck and Pfizer won approval from the U.S. Food and Drug Administration for Steglatro as a single therapy and in fixed-dose combinations with Merck’s diabetes drug Januvia or with metformin, an older generic treatment typically given to newly diagnosed patients”.
 
Diabetes can cause severe organ damage affecting the “eyes and kidneys” besides it can also raise significant risk of “heart attack and stroke”. With the progression of “type II diabetes” many patients require “additional treatments” to keep their “blood sugar levels” under “better control”.
References:
reuters.com







Science & Technology

Gene Editing of Human Embryo Could Find ‘Moral’ Grounds: UK’s Ethics Council

Baidu comes up with a self-driving bus

Developing countries are stepping up their own space programs

McAfee: Number of cybercrime attacks skyrocketed

RemoveDebris Mission To Clear Debris Of In Orbit Over Earth

British experts: Online gambling is dangerous

Vodafone Chooses ‘Highly Trafficked Urban’ Space As Its 5G Testing Grounds

Space To Become A Travel Destination By 2022

Dream Of Immortality Can Be Realised By 2045

Predicting A Patient’s Death Might Be Possible With Google’s Machine Learning Tool

World Politics

World & Politics

Germany asks to return € 4 thousand subsidies for the purchase of Tesla

Was Trump's visit to the UK the last straw?

Prime Minister May Could Alter Brexit Strategies, Said Ress-Mogg

Le Maire: The US refused to release France from anti-Iran sanctions

One Belt, One Road is facing difficulties around the world

Qatar to raise $ 4 billion to buy Eurofighter Typhoon jets

The UK sets to turn all cars zero-emission by 2030

Brexit Minister’s Resignation States May’s Brexit Policies Weakening The Country’s Stance